Association of Multiple Gene Polymorphisms Including Homozygous NUDT15 R139C With Thiopurine Intolerance During the Treatment of Acute Lymphoblastic Leukemia. Issue 8 (November 2021)

• Record Type: Journal Article
• Authors: Kudo, Ko; Sato, Tomohiko; Takahashi, Yuka; Yuzawa, Kentaro; Kobayashi, Akie; Kamio, Takuya; Sasaki, Shinya; Shimada, Jun; Otani, Katsuki; Tusjimoto, Shinichi; Kato, Motohiro; Toki, Tsutomu; Terui, Kiminori; Ito, Etsuro
• Is Part Of: Journal of pediatric hematology/oncology. Volume 43:Issue 8(2021)
• Publication Date: 2021-11
• Subjects: acute lymphoblastic leukemia -- child -- mercaptopurine -- NUDT15; Pediatric hematology -- Periodicals; Tumors in children -- Periodicals; 618.9215
• DOI: 10.1097/MPH.0000000000002085
• Languages: English
• ISSNs: 1077-4114

Abstract

Abstract : Although thiopurine is a crucial drug for treating acute lymphoblastic leukemia, individual variations in intolerance are observed due to gene polymorphisms. A 3-year-old boy with B-cell precursor acute lymphoblastic leukemia who was administered thiopurine developed mucositis, sepsis, and hemophagocytic lymphohistiocytosis due to prolonged hematologic toxicity, chronic disseminated candidiasis, and infective endocarditis that triggered multiple brain infarctions. The patient was found to harbor 3 gene polymorphisms associated with thiopurine intolerance including homozygous NUDT15 R139C, heterozygous ITPA C94A, and homozygous MTHFR C677T and heterozygous RFC1 G80A. Thus, the combined effect of intolerance via multiple gene polymorphisms should be considered in case of unexpected adverse reactions. Abstract : Supplemental Digital Content is available in the text.